Insider Transactions in Q4 2020 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
8,679
+4.51%
|
-
|
|
Dec 29
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
8,679
-10.25%
|
-
|
|
Dec 14
2020
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Open market or private sale
|
Direct |
1,856
-8.59%
|
$148,480
$80.0 P/Share
|
|
Dec 10
2020
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
5,909
-8.53%
|
$407,721
$69.64 P/Share
|
|
Dec 08
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
40,764
-9.79%
|
$2,853,480
$70.96 P/Share
|
|
Dec 07
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
63,078
-8.12%
|
$4,478,538
$71.36 P/Share
|
|
Dec 05
2020
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,906
-4.02%
|
$206,326
$71.72 P/Share
|
|
Dec 05
2020
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,861
+7.51%
|
-
|
|
Nov 12
2020
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Open market or private sale
|
Direct |
12,124
-35.95%
|
$909,300
$75.48 P/Share
|
|
Nov 06
2020
|
Daniel A. Camardo EVP and President, U.S. |
SELL
Open market or private sale
|
Direct |
3,500
-10.2%
|
$266,000
$76.76 P/Share
|
|
Nov 05
2020
|
Jeff Kent Officer |
SELL
Open market or private sale
|
Direct |
47,944
-14.63%
|
$3,787,576
$79.91 P/Share
|
|
Nov 05
2020
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Open market or private sale
|
Direct |
77,500
-12.83%
|
$6,122,500
$79.87 P/Share
|
|
Nov 01
2020
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,503
-39.46%
|
$407,222
$74.93 P/Share
|
|
Nov 01
2020
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,420
+47.11%
|
-
|
|
Oct 21
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+31.7%
|
$91,000
$7.61 P/Share
|
|
Oct 01
2020
|
Daniel A. Camardo EVP and President, U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,460
-11.5%
|
$356,800
$80.42 P/Share
|
|
Oct 01
2020
|
Daniel A. Camardo EVP and President, U.S. |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+20.5%
|
-
|